ARWR

Arrowhead Pharmaceuticals
D

ARWR

61.670
USD
2.14
(3.59%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
55,619
الربح لكل سهم
-3
العائد الربحي
-
P/E
-27
حجم السوق
8,711,162,980
أصول ذات صلة

العنوان: Arrowhead Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products andclinical candidates designed to target different cell types within the body.

أسئلة شائعة حول سهم Arrowhead Pharmaceuticals